On May 11, 2026, Sotera Health Co announced an underwriting agreement for the sale of 31,838,253 shares at $15.168 per share, which was executed on May 13, 2026. The sale marks the end of special governance rights for prior equity sponsors, Warburg Pincus LLC and GTCR LLC, who will no longer hold shares in the company.